Narayana Hrudayalaya will host a one-on-one investor meeting with FSSA Investment Managers on Thursday, August 20, 2026, at 10:30 am. The session will be conducted as a physical meeting, providing institutional investors with direct access to the company’s management team.

The intimation was submitted to the listing departments of both the Bombay Stock Exchange and the National Stock Exchange on August 18, 2026. The disclosure was made in compliance with Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

Sridhar S., Group Company Secretary and Legal & Compliance Officer, signed the communication. The schedule remains tentative and may be subject to change due to exigencies on the part of the analysts, investors, or the company.

Narayana Hrudayalaya Limited declared the voting results for its 26th Annual General Meeting (AGM) on August 17, 2026, confirming that all 11 resolutions placed before shareholders were approved. The results, along with the Scrutinizer’s Report dated August 17, 2026, were submitted to the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Participation and Results

The AGM was conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM) on Friday, August 14, 2026, commencing at 11:30 am and concluding at 12:57 pm (IST). Dr. Devi Prasad Shetty, Chairman, welcomed members to the session, which was conducted in compliance with the Companies Act, 2013, and SEBI regulations.

Remote e-voting facilities were available from Tuesday, August 11, 2026, at 9:00 am until Thursday, August 13, 2026, at 5:00 pm. Members participating in the AGM who had not cast their votes remotely were eligible to vote electronically on the National Securities Depository Limited (NSDL) portal during the meeting. Mr. Sudhindra K S, Practicing Company Secretary, served as the Scrutinizer for the process.

As of the record date, there were 213,194 shareholders. Attendance via VC included six promoters/promoter group members and 55 public shareholders. No shareholders attended in person or through proxy. The total number of shares held by eligible voters stood at 20,43,60,804.

Resolution Outcomes

All ordinary and special resolutions received overwhelming support, particularly from the promoter group which holds 12,93,08,730 shares (approximately 63% of the total equity). Institutional investors also participated significantly, with polling rates exceeding 80% for most resolutions.

Key Governance and Strategic Decisions

The most notable divergence in voting occurred regarding Resolution 4, the re-appointment of Dr. Kiran Mazumdar Shaw as a Director. While the promoter group voted unanimously in favour, public institutional investors cast 87,90,113 votes against the resolution, representing 27.82% of the votes polled by this category. Despite this opposition, the resolution passed with an overall support of 94.73% due to the promoter group’s decisive backing.

Other significant approvals included:

• Dividend Payout: Shareholders approved a final dividend of ₹4.50 per equity share for the financial year ended March 31, 2026.
• Board Appointments: Ms. Terri Smith Bresenham was reappointed as an Independent Director for a second term of five consecutive years, effective August 5, 2026.
• Remuneration Revisions: Special resolutions approving revised remuneration packages for Dr. Devi Prasad Shetty (Whole-time Director), Mr. Viren Prasad Shetty (Executive Vice Chairman), and Dr. Emmanuel Rupert (Managing Director and Group CEO) were all passed with support exceeding 99%.
• Debt Issuance: The company secured shareholder approval to issue debt securities on a private placement basis, providing flexibility for future capital raising needs.

Management Presentation Recap

During the AGM, Dr. Emmanuel Rupert, Managing Director and Group CEO, delivered a presentation outlining the company’s performance during FY25-26. Key discussion points included strategic growth initiatives, the acquisition of the hospital business of Practice Plus Group in the United Kingdom, international operations, digital and AI-enabled transformation, clinical research programmes, and sustainability commitments. The management team also addressed shareholder queries regarding consolidated revenues, financing of the UK acquisition, borrowings, deleveraging plans, operating metrics, capital expenditure, and employee strength.

Regulatory Compliance and Documentation

In accordance with Ministry of Corporate Affairs directions, the Notice, audited financial statements, Auditors Report, and Board's Report were sent via email to registered shareholders. Physical copies were dispatched only upon specific request. The proceedings of the AGM are available on the company’s website. Representatives of the Statutory Auditor, Deloitte Haskins & Sells LLP, and Secretarial Auditors, M/s. Vinod Kothari & Company, were present at the meeting.

Directors from various committees, including Audit, Risk and Compliance, Nomination and Remuneration, Corporate Social Responsibility, and Stakeholders' Relationship, attended via VC. The requisite quorum was present throughout the meeting.